544 related articles for article (PubMed ID: 8600155)
1. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
Reddy CC; Wells A; Lauffenburger DA
J Cell Physiol; 1996 Mar; 166(3):512-22. PubMed ID: 8600155
[TBL] [Abstract][Full Text] [Related]
2. Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect.
Reddy CC; Wells A; Lauffenburger DA
Biotechnol Prog; 1994; 10(4):377-84. PubMed ID: 7765094
[TBL] [Abstract][Full Text] [Related]
3. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses.
Starbuck C; Lauffenburger DA
Biotechnol Prog; 1992; 8(2):132-43. PubMed ID: 1368006
[TBL] [Abstract][Full Text] [Related]
4. Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
Yang SG; Ahmad S; Wong NC; Hollenberg MD
Mol Pharmacol; 1994 Aug; 46(2):256-65. PubMed ID: 8078489
[TBL] [Abstract][Full Text] [Related]
5. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
6. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
[TBL] [Abstract][Full Text] [Related]
7. Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line.
Korc M; Chandrasekar B; Shah GN
Cancer Res; 1991 Dec; 51(23 Pt 1):6243-9. PubMed ID: 1933884
[TBL] [Abstract][Full Text] [Related]
8. Engineering epidermal growth factor for enhanced mitogenic potency.
Reddy CC; Niyogi SK; Wells A; Wiley HS; Lauffenburger DA
Nat Biotechnol; 1996 Dec; 14(13):1696-9. PubMed ID: 9634854
[TBL] [Abstract][Full Text] [Related]
9. Mutations within subdomain II of the extracellular region of epidermal growth factor receptor selectively alter TGF alpha binding.
Harte MT; Gentry LE
Arch Biochem Biophys; 1995 Oct; 322(2):378-89. PubMed ID: 7574711
[TBL] [Abstract][Full Text] [Related]
10. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
[TBL] [Abstract][Full Text] [Related]
11. Comparative mitogenic potencies of EGF and TGF alpha and their dependence on receptor-limitation versus ligand-limitation.
Reddy CC; Wells A; Lauffenburger DA
Med Biol Eng Comput; 1998 Jul; 36(4):499-507. PubMed ID: 10198537
[TBL] [Abstract][Full Text] [Related]
12. The coupling between transforming growth factor-alpha and the epidermal growth factor receptor during rat liver regeneration.
Strömblad S; Andersson G
Exp Cell Res; 1993 Feb; 204(2):321-8. PubMed ID: 8440328
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha.
Rodeck U; Williams N; Murthy U; Herlyn M
J Cell Biochem; 1990 Oct; 44(2):69-79. PubMed ID: 2250044
[TBL] [Abstract][Full Text] [Related]
14. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
15. Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy.
Pittelkow MR; Cook PW; Shipley GD; Derynck R; Coffey RJ
Cell Growth Differ; 1993 Jun; 4(6):513-21. PubMed ID: 8373735
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
17. Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes.
Zyzak LL; MacDonald LM; Batova A; Forand R; Creek KE; Pirisi L
Cell Growth Differ; 1994 May; 5(5):537-47. PubMed ID: 8049160
[TBL] [Abstract][Full Text] [Related]
18. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line.
Korc M; Haussler CA; Trookman NS
Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor (EGF) receptor density controls mitogenic activation of normal rat kidney (NRK) cells by EGF.
Lahaye DH; Camps MG; Erp PE; Peters PH; Zoelen EJ
J Cell Physiol; 1998 Jan; 174(1):9-17. PubMed ID: 9397151
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and basic fibroblast growth factor (bFGF) differentially influence neural precursor cells of mouse embryonic mesencephalon.
Santa-Olalla J; Covarrubias L
J Neurosci Res; 1995 Oct; 42(2):172-83. PubMed ID: 8568917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
